TRP channels associated with macrophages as targets for the treatment of obese asthma

Wenzhao Zhu1, Dinxi Bai1, Wenting Ji2

  • 1Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China.

PubMed

Insights

Obesity worsens asthma by affecting fat cells. Targeting TRP channels in fat tissue may offer new treatments for obese asthma, a challenging condition.

Area of Science:

  • Physiology
  • Immunology
  • Pharmacology

Background:

  • Obesity and asthma are significant global health concerns.
  • Obesity is a major factor exacerbating asthma, creating a distinct obese asthma phenotype.
  • Current treatments for obese asthma are limited.

Purpose of the Study:

  • To investigate how obesity exacerbates asthma-related inflammation.
  • To explore transient receptor potential (TRP) channels as potential therapeutic targets for obese asthma.

Main Methods:

  • Review of existing literature on TRP channels, adipose tissue, and asthma.
  • Analysis of the role of TRP channels in adipokine and cytokine secretion.
  • Exploration of TRP channel function in adipose tissue metabolism and inflammation.

Main Results:

  • TRP channels are present in adipose tissue and influence thermogenesis and adipokine/cytokine release.
  • These mediators secreted by adipose tissue are implicated in asthma and obesity.
  • Obesity-induced inflammation may be modulated by TRP channel activity in adipocytes.

Conclusions:

  • Targeting TRP channels in adipose tissue presents a potential therapeutic strategy for obese asthma.
  • Further research into TRP channel function could provide novel insights into treating this condition.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
501